General Counsel
Wed, Jun 10, 2026
Jun 10
25,000 shares @ $5.10
Decreased holdings by -6.90%
3rd largest trade (out of 24)
Planned (10b5-1)
“The reported sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 48% above 200-day moving average
MRVIMARAVAI LIFESCIENCES HOLDINGS, INC.
HealthcareBiotechnology
1D0.00%
1W-0.69%
1M-17.88%
3M+28.12%
6M—
1Y—